Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant

Next deadline: Apr 7, 2024 (Letter of inquiry)

Later deadlines: May 5, 2024 (Letter of inquiry), May 7, 2024 (Full proposal), Jun 5, 2024 (Full proposal), Aug 7, 2024 (Letter of inquiry), Sep 5, 2024 (Letter of inquiry), Sep 7, 2024 (Full proposal), Oct 5, 2024 (Full proposal), Dec 7, 2024 (Letter of inquiry), Jan 5, 2025 (Letter of inquiry), Jan 7, 2025 (Full proposal), Feb 5, 2025 (Full proposal), Apr 7, 2025, May 5, 2025 (Letter of inquiry), May 7, 2025 (Full proposal), Jun 5, 2025 (Full proposal), Aug 7, 2025 (Letter of inquiry), Sep 5, 2025 (Letter of inquiry), Sep 7, 2025 (Full proposal), Oct 5, 2025 (Full proposal), Dec 7, 2025 (Letter of inquiry), Jan 7, 2026 (Full proposal)

Grant amount: Unspecified amount

Fields of work: Mental Health & Psychiatric Diseases

Applicant type: Government Entity, Indigenous Group, Nonprofit, For-Profit Business

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: The following deadlines apply to standard grant applications (due by 5:00 pm  local time of applicant organization):

  • February 5, 2023
  • June 5, 2023
  • October 5, 2023
  • February 5, 2024
  • June 5, 2024
  • October 5, 2024
  • February 5, 2025
  • June 5, 2025
  • October 5, 2025

Deadlines for AIDS-related projects are the following (due by 5:00 pm local time of applicant organization):

  •  May 7, 2023 
  • September 7, 2023
  • January 7, 2024
  • May 7, 2024
  • September 7, 2024
  • January 7, 2025
  • May 7, 2025
  • September 7, 2026

This Funding Opportunity Announcement (FOA) seeks to support collaborative clinical studies, not involving treatment development, efficacy, or effectiveness trials. Primary areas of focus include mental health genetics, biomarker studies, and studies of mental illnesses (e.g., psychopathology, neurodevelopmental trajectories of psychopathology) also when associated with HIV/AIDS. Applicants should apply to this FOA when two or more sites are needed to complete the study. Accordingly, the collaborating studies share a specific protocol across the sites and are organized as such in order to increase sample size, accelerate recruitment, or increase sample diversity and representation. In studies with a large number of sites, it is expected that one site will be submitted as a coordinating R01 for data management and/or other centralized administration.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)
FUNDER

Your history with this funder
0
SAVED OPPORTUNITIES
No saved opportunities from this funder yet
FUNDER NOTES
Save this opportunity to add notes...
CONTACTS
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Forecasted Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih) help icon

This page was last reviewed December 14, 2022 and last updated December 14, 2022